Endoplasmic reticulum protein ERp29 and doxorubicininduced toxicity in H9c2 cardiomyocytes: a comparative proteomics analysis

Guo, Liang; Guan, Jun; Xing, Mingqing; Wang, Zhengzhong; Hou, Fangjie; Xing, Conghui; Lei, Yuping

doi:10.5372/1905-7415.0603.073

Abstract

Background: Doxorubicin has been widely used to treat many cancers. It also induces cumulative and delayed cardiomyopathy. New biological markers to predict cardiac toxicity is needed.

Objectives: We identified novel markers and potential therapeutic targets of doxorubicin (DOX)-induced cardiac toxicity by proteomics approach.

Methods: The protein profiling of H9c2 cells in response to DOX at an apoptosis-induced concentration (0.5⃞M) were compared by two-dimensional electrophoresis (2-DE) and mass spectrometry.

Results: A total of nine differently expressed proteins were identified including six up-regulated and three downregulated proteins. We further confirmed the expression of two down-regulated proteins, prohibitin and endoplasmic reticulum protein ERp29 (ERp29), decreased in response to DOX induction by Western-blot, and over-expression of ERp29 also partially recovered the MTT reduction.

Conclusion: We first identified ERp29 and prohibitin as novel markers for DOX toxicity, and ERp29 might be a candidate target to develop novel therapeutic strategies to alleviate adverse effects of doxorubicin-based chemotherapies.

References

1. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998; 339:900-5.10.1056/NEJM199809243391307
Search in Google Scholar Back to article
2. Wallace KB. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol. 2003; 93: 105-15.10.1034/j.1600-0773.2003.930301.x
Search in Google Scholar Back to article
3. Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis. 2007; 49:330-52.10.1016/j.pcad.2006.10.002
Search in Google Scholar Back to article
4. Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem. 2002; 234-235:119-24.10.1023/A:1015976430790
Search in Google Scholar Back to article
5. Kumar SN, Konorev EA, Aggarwal D, Kalyanaraman B. Analysis of proteome changes in doxorubicintreated adult rat cardiomyocyte. J Proteomics. 2011; 74:683-97.10.1016/j.jprot.2011.02.013
Search in Google Scholar Back to article
6. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B. Doxorubicin induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem. 2000; 275:33585-92.10.1074/jbc.M003890200
Search in Google Scholar Back to article
7. Zhang B, Wang M, Yang Y, Wang Y, Pang X, Su Y, et al. ERp29 is a radiation-responsive gene in IEC-6 cell. J Radiat Res (Tokyo). 2008; 49:587-96.10.1269/jrr.08014
Search in Google Scholar Back to article
8. Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol. 2003; 35: 1135-43.10.1016/S0022-2828(03)00229-3
Search in Google Scholar Back to article
9. Liu X, Ren Z, Zhan R, Wang X, Wang X, Zhang Z, et al. Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte. Cell Stress Chaperones. 2009; 14:311-9.10.1007/s12192-008-0086-5
Open DOI Search in Google Scholar Back to article
10. Muraguchi T, Kawawa A, Kubota S. Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death. Biomed Res. 2010; 31:113-22.10.2220/biomedres.31.113
Search in Google Scholar Back to article
11. Baryshev M, Sargsyan E, Mkrtchian S. ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem Biophys Res Commun. 2006; 340:617-24.10.1016/j.bbrc.2005.12.052
Search in Google Scholar Back to article
12. Dukes AA, Van Laar VS, Cascio M, Hastings TG. Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine. J Neurochem. 2008; 106:333-46.10.1111/j.1471-4159.2008.05392.x
Search in Google Scholar Back to article
13. Stockwin LH, Bumke MA, Yu SX, Webb SP, Collins JR, Hollingshead MG, Newton DL. Proteomic analysis identifies oxidative stress induction by adaphostin. Clin Cancer Res. 2007; 13:3667-81.10.1158/1078-0432.CCR-07-0025
Open DOI Search in Google Scholar Back to article
14. Zhang D, Putti TC.Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp Cell Res. 2010; 316:3522-31.10.1016/j.yexcr.2010.08.014
Search in Google Scholar Back to article
15. Liu L, Zhang X, Qian B, Min X, Gao X, Li C, Cheng Y, Huang J. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice. Eur J Heart Fail. 2007; 9:762-9.10.1016/j.ejheart.2007.03.007
Open DOI Search in Google Scholar Back to article
16. Venkatakrishnan CD, Tewari AK, Moldovan L, Cardounel AJ, Zweier JL, Kuppusamy P, Ilangovan G. Heat shock protects cardiac cells from doxorubicininduced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol. 2006; 291:H2680-9110.1152/ajpheart.00395.2006
Search in Google Scholar Back to article

Endoplasmic reticulum protein ERp29 and doxorubicininduced toxicity in H9c2 cardiomyocytes: a comparative proteomics analysis

Abstract

Paradigm

My account